About Scinai
Scinai is a company based in Jerusalem (Israel) founded in 2023. The company has 31 employees as of December 31, 2024. Scinai has completed 1 acquisition, including PinCell. Scinai offers products and services including NanoAbs and CDMO Services. Scinai operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
- Headquarter Jerusalem, Israel
- Employees 31 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Scinai Immunotherapeutics Ltd. Sponsored Adr
-
Annual Revenue
$661.12 K (USD)0as on Dec 31, 2024
-
Net Profit
$4.82 M (USD)0as on Dec 31, 2024
-
EBITDA
-$7.02 M (USD)23.48as on Dec 31, 2024
-
Latest Funding Round
$1.69 M (USD), Post-IPO
Dec 29, 2023
- Investors
-
Employee Count
31
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Scinai
Scinai is a publicly listed company on the NASDAQ with ticker symbol SCNI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Scinai
Scinai offers a comprehensive portfolio of products and services, including NanoAbs and CDMO Services.
Antibodies targeting inflammatory diseases for therapeutic use
Contract development and manufacturing for biopharmaceutical processes
People of Scinai
Unlock access to complete
Unlock access to complete
Funding Insights of Scinai
Investors in Scinai
Scinai has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Israel Innovation Authority.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Business development in Israel is supported by a government organization.
|
Locked | Locked | Locked |
Investor details for Scinai
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Scinai
Scinai has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include PinCell.
Investment portfolio details for Scinai
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of anti-inflammatory therapy for the treatment skin diseases
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for Scinai
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Scinai
Detailed financials for Scinai
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Scinai Comparisons
Peer comparison for Scinai
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Scinai
Scinai operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| Locked | Locked | Locked |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| Locked | Locked | Locked |
Integrated biologics development and manufacturing are provided as a CDMO.
|
|
| Locked | Locked | Locked |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| Locked | Locked | Locked |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| Locked | Locked | Locked |
Vaccines and biologics are developed and manufactured by IDT Biologika.
|
Detailed competitors of Scinai
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Scinai
Complete news archive for Scinai
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scinai
Scinai was founded in 2023.
Scinai is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
As of Dec 31, 2024, the latest employee count at Scinai is 31.
Annual revenue of Scinai is $661.12K as on Dec 31, 2024.
Scinai Immunotherapeutics is a company that enables companies to go beyond carbon accounting and implement cost-effective carbon reduction strategies. They provide a decarbonization platform that helps companies take action towards reducing their carbon footprint.
Scinai's top competitors include KBI Biopharma, Aldevron and Ovagen.
Scinai offers NanoAbs and CDMO Services.
Yes, Scinai is publicly traded on NASDAQ under the ticker symbol SCNI.
Scinai has made 1 acquisition, including PinCell.
Scinai has 1 investor. Key investors include Israel Innovation Authority.
The ticker symbol of Scinai is SCNI on NASDAQ.